Seek Returns

ABBV vs. ASML: AbbVie vs. ASML Stock Comparison

How do AbbVie (ABBV) and ASML (ASML) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

AbbVie (ABBV) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas ASML (ASML) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

AbbVie (ABBV) trades as ordinary local shares, while ASML (ASML) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for AbbVie (ABBV) and ASML (ASML)
Profile ItemABBVASML
NameAbbVie Inc.ASML Holding N.V. NY Registered Shares
Country/RegionUnited StatesNetherlands
GICS SectorHealth CareInformation Technology
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesSemiconductors & Semiconductor Equipment
GICS IndustryBiotechnologySemiconductors & Semiconductor Equipment
GICS Sub-IndustryBiotechnologySemiconductor Materials & Equipment
Market Capitalization514.92 billion USD549.12 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateJanuary 2, 2013March 15, 1995
Security TypeCommon StockADR

Price Performance

Cumulative Growth

ABBV
ASML
GSPC
Loading price history…
AbbVie (ABBV) vs. ASML (ASML), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for AbbVie (ABBV) and ASML (ASML). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for AbbVie (ABBV) and ASML (ASML). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
Total Return (1Y)37.33%50.12%
Total Return (3Y, Annualized)32.74%34.80%
Total Return (5Y, Annualized)24.73%13.32%

Risk Profile

Drawdown History

ABBV
ASML
GSPC
Loading price history…
AbbVie (ABBV) vs. ASML (ASML), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for AbbVie (ABBV) and ASML (ASML). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

ASML (ASML) has an aggressive beta of 1.80, indicating higher sensitivity to broad-market moves, while AbbVie (ABBV) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk profile metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
Volatility (1Y, Annualized)25.65%48.80%
Beta (5Y)0.211.80
Max Drawdown (5Y)-21.92%-56.47%
Avg. Volume (3M)4.76M1.42M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ABBV and ASML are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
Sharpe Ratio (1Y)1.290.94
Sortino Ratio (1Y)2.021.39

Profitability

ROE (TTM)

Capital efficiency shows on one side only: ASML (ASML) earns 65.64% on shareholders’ equity, ranked against its industry; AbbVie (ABBV) has no ROE this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ABBV
--

ASML

Semiconductors & Semiconductor Equipment industry group

65.64%

ASML
65.64%
Max
52.82%
Q3
22.26%
Median
10.58%
Q1
1.29%
Min
-16.89%
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): ABBV does not report ROE, so it has no value marker; ASML is benchmarked against the Semiconductors & Semiconductor Equipment industry group.

Net Margin (TTM)

For every dollar of sales, both AbbVie (ABBV) at 15.67% and ASML (ASML) at 34.14% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

15.67%

Max
18.05%
ABBV
15.67%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

ASML

Semiconductors & Semiconductor Equipment industry group

34.14%

Max
63.80%
ASML
34.14%
Q3
28.36%
Median
11.44%
Q1
0.90%
Min
-37.77%
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Operating Margin (TTM)

Both AbbVie (ABBV) at 39.59% and ASML (ASML) at 44.36% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

39.59%

Max
83.12%
ABBV
39.59%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

ASML

Semiconductors & Semiconductor Equipment industry group

44.36%

Max
58.66%
ASML
44.36%
Q3
30.23%
Median
15.91%
Q1
7.54%
Min
-25.74%
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Profitability Metrics

Profitability metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
ROE (TTM)--65.64%
ROA (TTM)10.74%18.28%
Net Margin (TTM)15.67%34.14%
Operating Margin (TTM)39.59%44.36%
Gross Margin (TTM)73.72%54.34%

Growth

Revenue Growth

Both AbbVie (ABBV) at 8.57% and ASML (ASML) at 15.58% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both AbbVie (ABBV) at -0.84% and ASML (ASML) at 28.43% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
Revenue Growth (YoY)8.57%15.58%
Revenue Growth (3Y CAGR)1.75%15.55%
EPS Growth (YoY)-0.84%28.43%
EPS Growth (3Y CAGR)-29.03%15.42%

Financial Strength

Current Ratio (MRQ)

Both AbbVie (ABBV) at 0.87 and ASML (ASML) at 1.49 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.87

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
ABBV
0.87
Min
0.10

ASML

Semiconductors & Semiconductor Equipment industry group

1.49

Max
10.33
Q3
5.62
Median
3.33
Q1
2.35
ASML
1.49
Min
1.03
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Debt / Equity (MRQ)

Only one side’s leverage can be read here: ASML (ASML) carries debt-to-equity ratio of 0.09 against its industry range, while AbbVie (ABBV) reports no figure this period.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
ABBV
--

ASML

Semiconductors & Semiconductor Equipment industry group

0.09

Max
1.46
Q3
0.65
Median
0.27
ASML
0.09
Q1
0.04
Min
0.00
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): ABBV does not report debt-to-equity ratio, so it has no value marker; ASML is benchmarked against the Semiconductors & Semiconductor Equipment industry group.

Financial Strength Metrics

Financial strength metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
Current Ratio (MRQ)0.871.49
Debt / Equity (MRQ)--0.09
Net Debt / EBITDA2.21-0.67

Dividends

Dividend Yield (TTM)

ASML (ASML) at 0.55% pays an industry-typical yield; AbbVie (ABBV) at 2.40% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40%

ABBV
2.40%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ASML

Semiconductors & Semiconductor Equipment industry group

0.55%

Max
1.37%
Q3
0.65%
ASML
0.55%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Payout Ratio (TTM)

AbbVie (ABBV) reports payout ratio above 100% at 117.35%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile ASML (ASML) reports 22.26%, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

117.35%

ABBV
117.35%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ASML

Semiconductors & Semiconductor Equipment industry group

22.26%

Max
49.64%
ASML
22.26%
Q3
21.71%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Dividend Metrics

Dividend metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
Dividend Yield (TTM)2.40%0.55%
Dividend Payout Ratio (TTM)117.35%22.26%

Valuation

P/E Ratio (TTM)

ASML (ASML) at 35.06 is near its industry’s usual P/E ratio, while AbbVie (ABBV) at 50.05 sits in the richer quartile — ABBV needs stronger growth or earnings quality to justify the premium.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

50.05

Max
85.34
ABBV
50.05
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07

ASML

Semiconductors & Semiconductor Equipment industry group

35.06

Max
110.34
Q3
66.81
Median
37.02
ASML
35.06
Q1
23.96
Min
8.12
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/S Ratio (TTM)

AbbVie (ABBV) at 7.80 is priced about in line with its industry on P/S ratio, while ASML (ASML) at 13.91 sits in the pricier quartile — ASML costs more per dollar of sales.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

7.80

Max
58.18
Q3
25.77
ABBV
7.80
Median
7.30
Q1
3.01
Min
0.01

ASML

Semiconductors & Semiconductor Equipment industry group

13.91

Max
21.42
ASML
13.91
Q3
12.27
Median
5.76
Q1
2.73
Min
0.00
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

P/B Ratio (MRQ)

AbbVie (ABBV) reports a negative P/B ratio of -112.34, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile ASML (ASML) reports 1,223.36, ranking against industry peers normally.

ABBV

Pharmaceuticals, Biotechnology & Life Sciences industry group

-112.34

Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
ABBV
-112.34

ASML

Semiconductors & Semiconductor Equipment industry group

1,223.36

ASML
1,223.36
Max
14.06
Q3
7.44
Median
4.29
Q1
2.30
Min
0.20
Loading chart…
AbbVie (ABBV) vs. ASML (ASML): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Semiconductors & Semiconductor Equipment industry group benchmarks.

Valuation Metrics

Valuation metrics for AbbVie (ABBV) and ASML (ASML)
MetricABBVASML
P/E Ratio (TTM)50.0535.06
P/S Ratio (TTM)7.8013.91
P/B Ratio (MRQ)-112.341,223.36
Free Cash Flow Yield (TTM)3.44%1.89%